Suppr超能文献

使用vitaFlow liberty系统进行经导管主动脉瓣置换术后主动脉瓣疾病患者永久性起搏器植入的预测因素

Predictors of permanent pacemaker implantation in aortic valve diseases after TAVI with vitaFlow liberty system.

作者信息

Ju Changlin, Xie Xiangrong, Tang Shengxin, Cao Shiping

机构信息

Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of Cardiology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.

出版信息

Front Cardiovasc Med. 2023 Sep 29;10:1277528. doi: 10.3389/fcvm.2023.1277528. eCollection 2023.

Abstract

INTRODUCTION

Permanent pacemaker implantation (PPI) is a known complication in patients with aortic stenosis following transcatheter aortic valve implantation (TAVI). However, there is limited research on TAVI for pure aortic regurgitation (PAR), and more investigation is needed to determine the occurrence of postoperative cardiac conduction block and the need for PPI in this population. Therefore, this retrospective analysis aimed to evaluate the incidence of cardiac conduction block and the necessity of PPI after TAVI in patients with different types of aortic valve disease, including pure aortic stenosis (PAS), aortic stenosis with regurgitation (ASR), and PAR.

METHODS

Clinical data of 100 patients who TAVI were analyzed retrospectively. The incidence of conduction block was assessed, and clinical factors were examined to predict the necessity of PPI.

RESULTS

Cardiac conduction block was found to be a common complication following TAVI, particularly in patients with PAR. PAR was identified as an independent risk factor for requiring PPI. Additionally, first-degree atrioventricular block emerged as a sensitive predictor for PPI in patients with PAR.

DISCUSSION

These findings provide valuable insights into the safety and effectiveness of TAVI, which can help enhance patient management and reduce complications.

摘要

引言

永久性起搏器植入术(PPI)是经导管主动脉瓣植入术(TAVI)后主动脉瓣狭窄患者的一种已知并发症。然而,关于单纯主动脉瓣反流(PAR)的TAVI研究有限,需要更多研究来确定该人群术后心脏传导阻滞的发生率以及PPI的必要性。因此,这项回顾性分析旨在评估不同类型主动脉瓣疾病患者(包括单纯主动脉瓣狭窄(PAS)、主动脉瓣狭窄伴反流(ASR)和PAR)TAVI后心脏传导阻滞的发生率以及PPI的必要性。

方法

回顾性分析100例行TAVI患者的临床资料。评估传导阻滞的发生率,并检查临床因素以预测PPI的必要性。

结果

发现心脏传导阻滞是TAVI后的常见并发症,尤其是在PAR患者中。PAR被确定为需要PPI的独立危险因素。此外,一度房室传导阻滞是PAR患者PPI的敏感预测指标。

讨论

这些发现为TAVI的安全性和有效性提供了有价值的见解,有助于加强患者管理并减少并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/10570722/e43cb37b3acd/fcvm-10-1277528-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验